Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62,909 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE.
Zeng D, Fang Y, Fei Y, Liang R, Ye H, Liang Y, Sun X, Wang M, Huang H, Qiu L, Che Y, Liu P, Wang Y, Pan T, Lv Y, Deng J, Yi S, He Y, Xiao L, Lv H, Feng J, Zhang H, Zhou H, Zou D, Cai Q. Zeng D, et al. Among authors: wang y, wang m. Int J Cancer. 2023 Sep 1;153(5):1016-1025. doi: 10.1002/ijc.34565. Epub 2023 May 19. Int J Cancer. 2023. PMID: 37204683
Smoldering mantle cell lymphoma.
Ye H, Desai A, Zeng D, Nomie K, Romaguera J, Ahmed M, Wang ML. Ye H, et al. Among authors: wang ml. J Exp Clin Cancer Res. 2017 Dec 15;36(1):185. doi: 10.1186/s13046-017-0652-8. J Exp Clin Cancer Res. 2017. PMID: 29246179 Free PMC article. Review.
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
Romaguera JE, Wang M, Feng L, Fayad LE, Hagemeister F, McLaughlin P, Rodriguez MA, Fanale M, Orlowski R, Kwak LW, Neelapu S, Oki Y, Pro B, Younes A, Samaniego F, Fowler N, Hartig K, Valentinetti M, Smith J, Ford P, Naig A, Medeiros LJ, Kantarjian HM, Goy A. Romaguera JE, et al. Among authors: wang m. Cancer. 2018 Jun 15;124(12):2561-2569. doi: 10.1002/cncr.31361. Epub 2018 May 3. Cancer. 2018. PMID: 29723393 Free article. Clinical Trial.
The B cell receptor signaling pathway in mantle cell lymphoma.
Merolle MI, Ahmed M, Nomie K, Wang ML. Merolle MI, et al. Among authors: wang ml. Oncotarget. 2018 Mar 27;9(38):25332-25341. doi: 10.18632/oncotarget.25011. eCollection 2018 May 18. Oncotarget. 2018. PMID: 29861875 Free PMC article. Review.
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.
Jain P, Kanagal-Shamanna R, Zhang S, Ahmed M, Ghorab A, Zhang L, Ok CY, Li S, Hagemeister F, Zeng D, Gong T, Chen W, Badillo M, Nomie K, Fayad L, Medeiros LJ, Neelapu S, Fowler N, Romaguera J, Champlin R, Wang L, Wang ML. Jain P, et al. Among authors: wang l, wang ml. Br J Haematol. 2018 Nov;183(4):578-587. doi: 10.1111/bjh.15567. Epub 2018 Sep 2. Br J Haematol. 2018. PMID: 30175400 Free article.
62,909 results
You have reached the last available page of results. Please see the User Guide for more information.